Global Coordination of Antimicrobial
Resistance Research

The Joint Programming Initiative on Antimicrobial Resistance, JPIAMR, is a global collaborative organisation and platform, engaging 29 nations to curb antimicrobial resistance (AMR) with a One Health approach.

29

countries

156

projects & networks

141

M€ invested

Strategic Research & Innovation Agenda

The JPIAMR Strategic Research and Innovation Agenda on Antimicrobial Resistance (SRIA) presents an overview of recent developments and future needs for AMR research.

AMR Knowledge Hub

JPIAMR provides here access to a collection of resources on AMR research networks, research performing institutes or centres and infrastructures.

One Health AMR

The candidate European Partnership on One Health Antimicrobial Resistance (OH AMR) is prepared by the Coordination and Support Action DESIGN OH AMR in collaboration with JPIAMR and other stakeholders.

Latest events

Fungal resistance workshop event picture

Tackling the emerging threat of fungal drug resistance

Jun 23, 2022 14:00 - Jun 23, 2022 (CEST)

Invasive fungal infections pose a threat to public health and are an under-recognized component of antimicrobial resistance, an emerging crisis worldwide. This live webinar will discuss the emerging threat of fungal drug resistance and identify opportunities and priorities in fungal resistance research.

Developing Diagnostic tools for Drug Resistant Infections for Human and Animal Health

Jun 22, 2022 13:30 - Jun 22, 2022 (CEST)

In this workshop we will explore the main barriers to industry in developing diagnostic tools for drug-resistant infections for human and animal health and how JPIAMR and other stakeholders (industry, academia, funders, and regulatory agencies, among others) can work together to improve the translation of these developments.

Developing Novel Antimicrobial Therapeutics

Jun 21, 2022 13:00 - Jun 21, 2022 (CEST)

JPIAMR, in partnership with Innovate UK KTN, are hosting this innovation workshop to provide information about the challenges in translating academic research to commercial and not-for-profit technology solutions.

Vaccination as a strategy to combat Antimicrobial Resistance

Jun 17, 2022 13:00 - Jun 17, 2022 (CEST)

Vaccination programs are known to be effective to both promote the prudent use of antibiotics and to prevent the spread of AMR. This webinar aims to identify opportunities and priorities for vaccine research from an immunological perspective to a wider translational context, in the field of antimicrobial resistance.

View all events

Latest news

Pre-announcement: Research call on AMR diagnostics and surveillance

Nov 18, 2022

We are pleased to pre‐announce the transnational call “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance”. The call involves 21 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.

Six new networks the area of diagnostics and surveillance

Nov 18, 2022

Six networks have been recommended for funding within the JPIAMR 15th transnational call: Diagnostics and Surveillance Networks. The networks include 228 partners from 40 countries and for the first time, a network focussed on antifungal resistance has been included.

New projects in the area of therapeutics

Nov 18, 2022

Thirteen projects involving 72 partners from 15 different countries have been recommended for funding within the JPIAMR 14th transnational call: Disrupting drug Resistance Using Innovative Design. The call was within the framework of the ERA‐NET JPIAMRACTION and the total funding amount is 15,4 M€.

Reports from DESIGN OH AMR consultations available

Oct 5, 2022

In 2022, the Coordination and Support Action (CSA) DESIGN OH AMR has organised a series of stakeholder and expert consultations to collect input to the update of the research and innovation objectives within the JPIAMR SRIA.

View all news